You are here

  • Home
  • Archive
  • Volume 8, Issue 4
  • The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)

Article metrics

Article menu

Download PDFPDF

Liver
Research
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)

 

Online download statistics by month:

Online download statistics by month: April 2017 to October 2024

AbstractFullPdf
Apr 2017170759
May 2017589979
Jun 201724083461
Jul 201722022239
Aug 20171019734
Sep 201719419549
Oct 201720620772
Nov 2017518523135
Dec 201784084246
Jan 201888388366
Feb 201843341247
Mar 201833132848
Apr 201821622247
May 201820020232
Jun 201814114029
Jul 201810410431
Aug 201813013026
Sep 2018767526
Oct 201814915026
Nov 201823423418
Dec 201832132019
Jan 201925225231
Feb 201921821526
Mar 2019969327
Apr 2019312730
May 2019353430
Jun 2019272722
Jul 2019303024
Aug 2019434223
Sep 2019282419
Oct 2019464034
Nov 2019474724
Dec 201910710322
Jan 2020272721
Feb 2020433622
Mar 202015214820
Apr 2020100979
May 2020373613
Jun 2020323120
Jul 2020363618
Aug 2020332912
Sep 202050455
Oct 2020524015
Nov 2020312923
Dec 2020322615
Jan 202135337
Feb 202196949
Mar 202110810711
Apr 2021414012
May 2021464016
Jun 202128259
Jul 2021211716
Aug 2021363516
Sep 2021413515
Oct 2021777429
Nov 202111711421
Dec 2021858515
Jan 2022626412
Feb 202271668
Mar 2022736912
Apr 2022535316
May 2022747228
Jun 202211213130
Jul 2022626413
Aug 2022676213
Sep 2022464522
Oct 2022414215
Nov 2022262614
Dec 202225259
Jan 2023454212
Feb 202342415
Mar 202345469
Apr 2023222115
May 2023262611
Jun 202325262
Jul 2023181714
Aug 2023212110
Sep 202323236
Oct 2023534213
Nov 202362525
Dec 2023726710
Jan 202482808
Feb 202443439
Mar 2024454411
Apr 2024636023
May 2024302418
Jun 2024484715
Jul 2024393315
Aug 202451399
Sep 202415169
Oct 202434309
Total9475114982100